@article{1b196259db83414c8def48e0cc0fe249,
title = "Second primary cancer in survivors following concurrent chemoradiation for locally advanced non-small-cell lung cancer",
abstract = "Long-term cancer survivors risk development of second primary cancers (SPC). Vigilant follow-up may be required. We report outcomes of 92 patients who underwent chemoradiation for unresectable stage III non-small-cell lung cancer, with a median follow-up of 8.9 years. The incidence of SPC was 2.4 per 100 patient-years (95% confidence interval: 1.0-4.9).",
keywords = "Chemotherapy, Non-small-cell lung cancer, Radiotherapy, Second primary cancer",
author = "N. Takigawa and K. Kiura and Y. Segawa and Y. Watanabe and H. Kamei and T. Moritaka and T. Shibayama and H. Ueoka and K. Gemba and T. Yonei and M. Tabata and T. Shinkai and S. Hiraki and M. Takemoto and Susumu Kanazawa and K. Matsuo and Mitsune Tanimoto",
year = "2006",
month = nov,
day = "6",
doi = "10.1038/sj.bjc.6603422",
language = "English",
volume = "95",
pages = "1142--1144",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "9",
}
